Esi 08 Camp Targetmol
Esi 08 Esi 08 is an effective antagonist of epac2 with an ic50 of 8.4 μm. esi 08 selectively blocks camp induced epac activation but not camp mediated pka activation. This document details its mechanism of action, chemical properties, and provides comprehensive experimental protocols for its use in camp research. quantitative data are summarized for easy reference, and key signaling and experimental workflows are visualized to facilitate understanding.
Esi 08 Camp Targetmol Esi 08 is an effective antagonist of epac2 with an ic50 of 8.4 μm. esi 08 selectively blocks camp induced epac activation but not camp mediated pka activation. Esi 08 is a potent and selective antagonist of exchange proteins directly activated by camp (epacs). it inhibits both epac1 and epac2 with an ic₅₀ of 8.4 μm, effectively blocking camp induced epac activation while sparing camp mediated protein kinase a (pka) signaling. Description: esi 08 is an effective antagonist of epac2 with an ic50 of 8.4 μm. esi 08 selectively blocks camp induced epac activation but not camp mediated pka activation. Esi 08 is a potent and selective epac antagonist, which can completely inhibit both epac1 and epac2 (ic50 of 8.4 μm) activity. esi 08 selectively blocks camp induced epac activation, but does not inhibit camp mediated pka activation.
Used Esi 08 0064 Instrument Surgical Instruments For Sale Dotmed Description: esi 08 is an effective antagonist of epac2 with an ic50 of 8.4 μm. esi 08 selectively blocks camp induced epac activation but not camp mediated pka activation. Esi 08 is a potent and selective epac antagonist, which can completely inhibit both epac1 and epac2 (ic50 of 8.4 μm) activity. esi 08 selectively blocks camp induced epac activation, but does not inhibit camp mediated pka activation. Esi 08 is an effective antagonist of epac2 with an ic50 of 8.4 μm. esi 08 selectively blocks camp induced epac activation but not camp mediated pka activation. esi 08 (25 μm) does not alter camp induced type i and ii pka holoenzymes activation while h89, a selective pka inhibitor, blocked the type i or ii pka activities completely [1]. This technical support center provides comprehensive guidance for researchers, scientists, and drug development professionals utilizing esi 08 , a potent and selective antagonist of exchange protein directly activated by camp (epac). Catalogue number: add to favourites t11234 1 ml supplier: targetmol chemicals inc size: 1 ml $$ product is available in: currency: gbp eur £155.00 add to basket shipping is calculated in checkout product details shipping & handling related products. Esi 08 is a potent and selective epac antagonist, which can completely inhibit both epac1 and epac2 (ic50 of 8.4 μm) activity. esi 08 selectively blocks camp induced epac activation, but does not inhibit camp mediated pka activation [1].
Esi 08 0072 Esi 08 is an effective antagonist of epac2 with an ic50 of 8.4 μm. esi 08 selectively blocks camp induced epac activation but not camp mediated pka activation. esi 08 (25 μm) does not alter camp induced type i and ii pka holoenzymes activation while h89, a selective pka inhibitor, blocked the type i or ii pka activities completely [1]. This technical support center provides comprehensive guidance for researchers, scientists, and drug development professionals utilizing esi 08 , a potent and selective antagonist of exchange protein directly activated by camp (epac). Catalogue number: add to favourites t11234 1 ml supplier: targetmol chemicals inc size: 1 ml $$ product is available in: currency: gbp eur £155.00 add to basket shipping is calculated in checkout product details shipping & handling related products. Esi 08 is a potent and selective epac antagonist, which can completely inhibit both epac1 and epac2 (ic50 of 8.4 μm) activity. esi 08 selectively blocks camp induced epac activation, but does not inhibit camp mediated pka activation [1].
Esi 05 Camp Targetmol Catalogue number: add to favourites t11234 1 ml supplier: targetmol chemicals inc size: 1 ml $$ product is available in: currency: gbp eur £155.00 add to basket shipping is calculated in checkout product details shipping & handling related products. Esi 08 is a potent and selective epac antagonist, which can completely inhibit both epac1 and epac2 (ic50 of 8.4 μm) activity. esi 08 selectively blocks camp induced epac activation, but does not inhibit camp mediated pka activation [1].
Solution Cours Esi 08 Studypool
Comments are closed.